Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cytometry|June 17, 1998
EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurementsP Nagy, L Bene, M Balázs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCLPatrick R Hagner, Hsiling Chiu, Vivek S Chopra, et al.British Journal of Haematology|August 4, 2017
Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell-mediated cytotoxicityPatrick R Hagner, Hsiling Chiu, Maria Ortiz, et al.Journal of Translational Medicine|October 26, 2022
Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue SyndromeZheng Wang, Michelle F Waldman, Tara J Basavanhally, et al.British Journal of Haematology|December 17, 2013
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)Anita K Gandhi, Jian Kang, Courtney G Havens, et al.Antimicrobial Agents and Chemotherapy|August 17, 2011
Discovery of a novel class of orally active antifungal beta-1,3-D-glucan synthase inhibitorsScott S Walker, Yiming Xu, Ilias Triantafyllou, et al.European Urology|August 15, 2016
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate CancerNicholas J Vogelzang, Karim Fizazi, John M Burke, et al.Cancer Letters|February 9, 2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern EuropeK Szymańska, L E Moore, N Rothman, et al.Pageof 4